103 related articles for article (PubMed ID: 15650025)
1. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
Bonamy GM; Guiochon-Mantel A; Allison LA
Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
[TBL] [Abstract][Full Text] [Related]
2. Nuclear export of the oncoprotein v-ErbA is mediated by acquisition of a viral nuclear export sequence.
DeLong LJ; Bonamy GM; Fink EN; Allison LA
J Biol Chem; 2004 Apr; 279(15):15356-67. PubMed ID: 14729678
[TBL] [Abstract][Full Text] [Related]
3. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
4. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
[TBL] [Abstract][Full Text] [Related]
5. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
6. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
7. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of the oncoprotein v-ErbA to aggresomes.
Bondzi C; Brunner AM; Munyikwa MR; Connor CD; Simmons AN; Stephens SL; Belt PA; Roggero VR; Mavinakere MS; Hinton SD; Allison LA
Mol Cell Endocrinol; 2011 Jan; 332(1-2):196-212. PubMed ID: 21075170
[TBL] [Abstract][Full Text] [Related]
9. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers.
Subauste JS; Koenig RJ
Mol Endocrinol; 1998 Sep; 12(9):1380-92. PubMed ID: 9731706
[TBL] [Abstract][Full Text] [Related]
11. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
13. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
14. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
15. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats.
Zubkova I; Subauste JS
Mol Biol Rep; 2004 Jun; 31(2):131-7. PubMed ID: 15293789
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
17. The v-erbA oncogene (review).
Thormeyer D; Baniahmad A
Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
[TBL] [Abstract][Full Text] [Related]
18. Dimerization interfaces of v-erbA homodimers and heterodimers with retinoid X receptor alpha.
Shen Q; Subauste JS
J Biol Chem; 2000 Dec; 275(52):41018-27. PubMed ID: 11018031
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor, v-ErbA, and chromatin.
Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the DNA binding specificity and function of v-ErbA and thyroid hormone receptor alpha 1.
Subauste JS; Koenig RJ
J Biol Chem; 1995 Apr; 270(14):7957-62. PubMed ID: 7713893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]